ELTP 8-K: SEC filing
Elite Pharmaceuticals
Filed with the SEC on · accession 0001493152-26-051105
ELTP filed a 8-K (current report) with the SEC on Nov 12, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Summary of the filing
Elite Pharmaceuticals announced it will host a conference call on November 13, 2026 to discuss its financial results for the second quarter of fiscal year 2027 ended September 30, 2026.
Key details
✦ Ask GOAX AI about this filing — what it means for ELTP, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ELTP?
Click hereFrequently asked questions
What did ELTP file with the SEC on Nov 12, 2026?
ELTP filed a 8-K (SEC filing). Elite Pharmaceuticals announced it will host a conference call on November 13, 2026 to discuss its financial results for the second quarter of fiscal year 2027 ended September 30, 2026.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other ELTP SEC filings
Get alerts when ELTP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days